10X Genomics, Inc. (TXG)
73.58
-7.07
(-8.77%)
USD |
NASDAQ |
Oct 12, 12:22
10X Genomics Free Cash Flow (Quarterly) : 15.39M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.39M |
| March 31, 2026 | 24.52M |
| December 31, 2025 | 39.00M |
| September 30, 2025 | 42.53M |
| June 30, 2025 | 16.13M |
| March 31, 2025 | 32.46M |
| December 31, 2024 | -9.464M |
| September 30, 2024 | 17.75M |
| June 30, 2024 | 3.618M |
| March 31, 2024 | -18.64M |
| December 31, 2023 | 22.31M |
| September 30, 2023 | -40.74M |
| June 30, 2023 | -36.88M |
| March 31, 2023 | -9.407M |
| Date | Value |
|---|---|
| December 31, 2022 | -26.01M |
| September 30, 2022 | -46.14M |
| June 30, 2022 | -44.18M |
| March 31, 2022 | -48.94M |
| December 31, 2021 | -21.81M |
| September 30, 2021 | -46.44M |
| June 30, 2021 | -11.45M |
| March 31, 2021 | -42.95M |
| December 31, 2020 | -152.44M |
| September 30, 2020 | -56.94M |
| June 30, 2020 | -36.26M |
| March 31, 2020 | -10.66M |
| December 31, 2019 | 0.119M |
| September 30, 2019 | 0.848M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Twist Bioscience Corp. | -8.648M |
| Tempus AI, Inc. | -19.14M |
| Personalis, Inc. | -29.55M |
| Intellia Therapeutics, Inc. | -84.92M |
| Alamar Biosciences, Inc. (California) | -15.07M |